In vivo animal experiments showed that knockdown of eIF4E expression significantly inhibited breast tumor growth volume, while immunohistochemistry showed that knockdown of eIF4E decreased the expression of the mesenchymal marker vimentin. The gene discussed is EIF4E; the disease is breast neoplasm.